IL1B and neoplasm: Furthermore, TMR with a glycolytic preference instills a “domino effect” by mediating the aggregation of various glycolytic and chemoresistance activators (VEGF, IL-1β, IL-8, IL-6, TGF-β, and lactate) within the tumor stroma [100,101].